[Malaria and hemoglobin S: interactions in African children]

Area of Science:

• Genetics and Infectious Diseases
• Hematology
• Parasitology

Context:

• Plasmodium falciparum malaria is a major health concern, particularly in regions with high prevalence of genetic blood disorders.
• Sickle cell disease (SCD) and sickle cell trait (SCT) are common in malaria-endemic areas, leading to complex interactions.
• Previous research suggests a protective effect of sickle cell hemoglobin against malaria, but the extent and implications require further investigation.

Purpose:

• To investigate the prevalence of sickle cell genotypes (homozygous SS and heterozygous AS) in patients experiencing Plasmodium falciparum malaria attacks in Gabon.
• To assess the impact of sickle cell hemoglobin on the severity of malaria, including cerebral malaria.
• To evaluate the association between malaria parasitemia and the clinical manifestations of sickle cell disease.

Summary:

• A study in Gabon analyzed 300 Plasmodium falciparum malaria cases, finding lower proportions of sickle cell patients (SS or AS) in ordinary (6.2%) and cerebral malaria (3.2%) attacks compared to the general population (23.2%).
• Asymptomatic malaria carriage was equally frequent in children with and without sickle cell hemoglobin.
• These findings indicate that hemoglobin S provides substantial, though incomplete, protection against severe P. falciparum malaria.

Impact:

• The study highlights the protective role of hemoglobin S against severe malaria, reinforcing its evolutionary significance in malaria-endemic regions.
• The observed increase in anemia and vaso-occlusive crises in malaria-infected sickle cell patients suggests that subclinical malaria infections can worsen sickle cell disease.
• These results have implications for clinical management, emphasizing the need to consider malaria co-infection in sickle cell disease patients and to integrate malaria prevention and treatment strategies.